China In Vitro Diagnostics Market Share

Statistics for the 2023 & 2024 China In Vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. China In Vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

INSTANT ACCESS

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of China In Vitro Diagnostics Industry

The Chinese in vitro diagnostic market is moderately competitive and consists of some major players. Many players in this market are trying to expand their product portfolios in order to increase their global market share. These companies focus on strategies such as mergers and acquisitions, collaborations, and new product developments. Key players in the Chinese in vitro diagnostics market are Abbott Laboratories, Shanghai Kehua Bio-Engineering Co., Ltd., Autobio Diagnostics Co., Mindray Medical International Limited, and Maccura Biotechnology, among others.

China In-vitro Diagnostics (IVD) Market Leaders

  1. Autobio Diagnostics

  2. Mindray Medical International Limited

  3. Shanghai Kehua Bio-Engineering Co. Ltd.

  4. Maccura Biotechnology

  5. Xiamen Boson Biotech

*Disclaimer: Major Players sorted in no particular order

China In Vitro Diagnostics Market Concentration

China In-vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)